GS71:FRA
GSK plc
€21.94
arrow_upward
+1.15%(+0.25) 1D
Sep 3, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GS71...
Open
€21.76
High
€21.95
Low
€21.76
Mkt. cap
102.64B
Avg. vol.
502.00
Volume
140.00
52-wk high
€26.02
52-wk low
€16.55
No. of employees
67K
Open
€21.76
High
€21.95
Low
€21.76
Mkt. cap
102.64B
Avg. vol.
502.00
Volume
140.00
52-wk high
€26.02
52-wk low
€16.55
No. of employees
67K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
GSK stock gains on Hutchmed cancer-drug deal and mRNA flu vaccine progress
Pluang
·
3 hours ago
HUTCHMED stock jumps 17.8% on $1.3B GSK licensi...
The Globe and Mail
·
3 hours ago
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
Yahoo Finance
·
4 hours ago
HUTCHMED Lands GSK Deal Worth Up to $1.3B for KRAS-EGFR Cancer Therapy
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOEmma Walmsley | Emma Walmsley
Employees66.8K
FoundedDec 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com